Direct-injection LC–MS–MS method for high-throughput simultaneous quantitation of simvastatin and simvastatin acid in human plasma
Mohammed Jemal, Zheng Ouyang, Mark L. Powell · Journal of Pharmaceutical and Biomedical Analysis · 2000
Cited by 113 works. doi:10.1016/s0731-7085(00)00309-5
Authors
References
- Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug.
- The need for adequate chromatographic separation in the quantitative determination of drugs in biological samples by high performance liquid chromatography with tandem mass spectrometry
- The use of high-flow high performance liquid chromatography coupled with positive and negative ion electrospray tandem mass spectrometry for quantitative bioanalysis via direct injection of the plasma/serum samples
- In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase.
- Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations*
- Clinical Pharmacokinetics of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors
- Quantitation of the acid and lactone forms of atorvastatin and its biotransformation products in human serum by high-performance liquid chromatography with electrospray tandem mass spectrometry
- Determination of the HMG-CoA reductase inhibitors simvastatin, lovastatin, and pravastatin in plasma by gas chromatography/chemical ionization mass spectrometry
- Determination of simvastatin and its active metabolite in human plasma by column-switching high-performance liquid chromatography with fluorescence detection after derivatization with 1-bromoacetylpyrene
- Simultaneous determination of simvastatin and its hydroxy acid form in human plasma by high-performance liquid chromatography with UV detection